Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage

Jintao Lou,Fan Wu,Wuhui He,Rui Hu,Ziyi Cai,Guisheng Chen,Wenji Zhao,Zhigang Zhang,Yu Si

DOI: https://doi.org/10.1080/13510002.2024.2341470

2024-04-19

Redox Report

Abstract:Cisplatin is widely employed in clinical oncology as an anticancer chemotherapy drug in clinical practice and is known for its severe ototoxic side effects. Prior research indicates that the accumulation of reactive oxygen species (ROS) plays a pivotal role in cisplatin's inner ear toxicity. Hesperidin is a flavanone glycoside extracted from citrus fruits that has anti-inflammatory and antioxidant effects. Nonetheless, the specific pharmacological actions of hesperidin in alleviating cisplatin-induced ototoxicity remain elusive. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is a critical mediator of the cellular oxidative stress response, is influenced by hesperidin. Activation of Nrf2 was shown to have a protective effect against cisplatin-induced ototoxicity. The potential of hesperidin to stimulate Nrf2 in attenuating cisplatin's adverse effects on the inner ear warrants further investigation. This study employs both in vivo and in vitro models of cisplatin ototoxicity to explore this possibility. Our results reveal that hesperidin mitigates cisplatin-induced ototoxicity by activating the Nrf2/NQO1 pathway in sensory hair cells, thereby reducing ROS accumulation, preventing hair cell apoptosis, and alleviating hearing loss.

biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to study the specific mechanism by which Hesperidin alleviates Cisplatin-induced ototoxicity through the activation of the Nrf2/NQO1 pathway. Cisplatin is a chemotherapy drug widely used in clinical oncology, but it has severe ototoxic side effects that can lead to hearing loss. The paper points out that reactive oxygen species (ROS) play a key role in Cisplatin-induced inner ear toxicity. Hesperidin is a flavanone glycoside extracted from citrus fruits, known for its anti-inflammatory and antioxidant properties. However, the specific pharmacological action of Hesperidin in alleviating Cisplatin ototoxicity remains unclear.

The study investigates whether Hesperidin can reduce Cisplatin-induced damage to sensory hair cells in the inner ear by activating the Nrf2/NQO1 pathway through in vivo and in vitro experimental models. The results indicate that Hesperidin can indeed alleviate Cisplatin-induced ototoxicity by activating the Nrf2/NQO1 pathway, reducing ROS accumulation, preventing hair cell apoptosis, and mitigating hearing loss. These findings may provide evidence for the development of new treatments for Cisplatin-induced ototoxicity.